TD Private Client Wealth
AGIO icon

TD Private Client Wealth’s Agios Pharmaceuticals AGIO Stock Holding History

TD Private Client Wealth’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$898 Buy
+27
New +$945 ﹤0.01% 1549
2021
Q4 		– Sell
-11
Closed -$508 – 1163
2021
Q3 		$508 Hold
11
– – ﹤0.01% 1166
2021
Q2 		$606 Hold
11
– – ﹤0.01% 1160
2021
Q1 		$568 Hold
11
– – ﹤0.01% 1115
2020
Q4 		$477 Hold
11
– – ﹤0.01% 1087
2020
Q3 		$385 Hold
11
– – ﹤0.01% 1056
2020
Q2 		$588 Hold
11
– – ﹤0.01% 1009
2020
Q1 		$390 Hold
11
– – ﹤0.01% 987
2019
Q4 		$525 Buy
+11
New +$416 ﹤0.01% 988

Other funds holding AGIO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

TD Private Client Wealth's AGIO Position: Q3 2026 in Review

TD Private Client Wealth opened a new position in Agios Pharmaceuticals (AGIO) in Q3 2026: 27 shares worth $898. The stake represents ﹤0.01% of the portfolio and ranks #1549 among its holdings. This is a return to the name: TD Private Client Wealth previously reported a position in AGIO as recently as Q3 2021.

TD Private Client Wealth first reported a position in AGIO in Q4 2019 and has held it in 9 quarters since. 175 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • TD Private Client Wealth held 27 shares of Agios Pharmaceuticals worth $898 as of Q3 2026.
  • Agios Pharmaceuticals was a new TD Private Client Wealth position in Q3 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of TD Private Client Wealth's portfolio in Q3 2026, its #1549 holding.
  • TD Private Client Wealth first reported a position in Agios Pharmaceuticals in Q4 2019 and has held it in 9 quarters since.
  • 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on TD Private Client Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.